| PUBCHEM ID |
72710669
|
| UNII |
75T1HFY189
|
| Preferred Term |
SULFATED CASTOR OIL
|
| CAS |
8002-33-3
|
| INCHIKEY |
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCCCCC[C@H](C/C=C\CCCCCCCC(OC[C@@H](COC(CCCCCCC/C=C\C[C@H](CCCCCC)OS(O)(=O)=O)=O)OC(CCCCCCC/C=C\C[C@H](CCCCCC)OS(O)(=O)=O)=O)=O)OS(O)(=O)=O
|
| Total Surface Area |
961,98
|
| Relative PSA |
0,23302
|
| TPSA |
294,84
|
| cLogS |
-8,712
|
| MW |
1173,63
|
| cLogP |
13,155
|
| H-Acceptors |
18
|
| H-Donors |
3
|
| Ro5 violations |
3
|
| Druglikeness |
-26,158
|
| DrugScore |
6,40285047742917E-02
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,0036
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,4097
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,8358
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,2743
|
| Carcinogenicity (Three-class) |
Non-required
|
